Alcon: all 719 studies

Page 7 of 8. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of FID 114657 on Tear Film Lipid Layer ThicknessCompletedNCT00848068Not applicable
• Effect on Wound Healing of Vigamox Versus CravitCompletedNCT00840580Phase 4
• A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye PatientsCompletedNCT00840268Phase 2
• DuoTrav® Eye Drops As Replacement Therapy ProgramCompletedNCT00828906Phase 4
• Systane Clinical Experience StudyCompletedNCT00818909Phase 4
• Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane SurgeryCompletedNCT00818844Phase 4
• Corneal Astigmatism Measurement StudyCompletedNCT00818532
• Kynex Versus Refresh Plus Study in Subject With Dry EyeCompletedNCT00809198Phase 4
• Residence Time Evaluation of Marketed OTC Ophthalmic ProductsCompletedNCT00804791Not applicable
• A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular HypertensionTerminatedNCT00788541Phase 2
• A 2-week Clinical Comparison of SYSTANE® Ultra to Sensitive Eyes Rewetting Drops in Contact Lens Wearing Patients.CompletedNCT00769665
• Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPTTerminatedNCT00767494Phase 3
• 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPTTerminatedNCT00767481Phase 3
• Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT00761995Phase 4
• Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00761709Phase 2
• Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® ToricWithdrawnNCT00761488Phase 4
• Safety and Efficacy of Travoprost/Timolol BAC-freeCompletedNCT00760539Phase 3
• Visual Outcome and Visual Quality After Bilateral Implantation of the AcrySof® IQ IOL Compared to MI60® and Tecnis® IOLWithdrawnNCT00760058Phase 4
• Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up TimeCompletedNCT00760045Phase 2
• Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT00759239Phase 4
• Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOLWithdrawnNCT00758940Phase 4
• A Phase III Study of an Otic Formulation in Acute Otitis ExternaCompletedNCT00750633Phase 3
• Evaluate Artificial Tear Efficacy in Moderate to Severe Dry EyeCompletedNCT00724412Phase 4
• Comparison of OPTI-FREE RepleniSH and ReNu Multi-Plus Lens Care Regimens on Corneal EpitheliumCompletedNCT00724269Not applicable
• Wettability of Contact Lenses With a Multi-Purpose SolutionCompletedNCT00713076Not applicable
• A Multi-Dose Study With a Treatment for Open-Angle GlaucomaWithdrawnNCT00705770Phase 2/3
• Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00691717Phase 2/3
• Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)CompletedNCT00691639
• Comparison of 3 Novel Contact Lens Solutions on the Basal LaminaCompletedNCT00691457Not applicable
• Glaucoma Adherence Study, SpainCompletedNCT00680329
• Glaucoma Adherence StudyCompletedNCT00676637
• A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00672997Phase 3
• Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00670033Phase 2
• Staining in a Healthy, Non-Dry Eye PopulationCompletedNCT00643942
• 24 Hour IOP Lowering Efficacy of AL-3789CompletedNCT00643669Phase 2
• Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose TravoprostCompletedNCT00637130Phase 2
• Adjunctive Study of AL-37807 Ophthalmic SuspensionCompletedNCT00620256Phase 2
• The Natural History of Geographic Atrophy Progression (GAP) StudyTerminatedNCT00599846
• Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy TubesCompletedNCT00579189Phase 3
• A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal InfiltratesTerminatedNCT00579020Phase 2
• A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube OtorrheaCompletedNCT00578773Phase 2
• A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy TubesCompletedNCT00578474Phase 3
• Patient Preference StudyCompletedNCT00576342Phase 3
• Safety and Efficacy of Vitreous Delineating Agent During VitrectomyCompletedNCT00532415Phase 3
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00527501Phase 2
• Ocular Hypotensive Efficacy of AR-102CompletedNCT00523250Phase 2
• Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTravCompletedNCT00519753Phase 4
• A Clinical Study of Tobradex AFCompletedNCT00473070Phase 3
• Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry EyeCompletedNCT00471419Phase 3
• Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy VolunteersCompletedNCT00468988Phase 4
• A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular HypertensionCompletedNCT00465803Phase 3
• Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00465621Phase 2
• Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle GlaucomaCompletedNCT00451152Phase 2
• Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin TherapyCompletedNCT00444665Phase 4
• Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and PlaceboCompletedNCT00405730Phase 3
• Tobradex BID Compared to TOBRADEX and TOBREX/VehicleWithdrawnNCT00404937Phase 3
• Mast-Cell Stabilizing Effects of OlopatadineCompletedNCT00389025Phase 4
• Effect of Multi-Purpose Solutions on Ex-Vivo Wetting AnglesCompletedNCT00383201Not applicable
• Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Silicone Hydrogel Soft Contact LensesCompletedNCT00382902Not applicable
• Evaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact LensesCompletedNCT00382681Not applicable
• Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic PatientsCompletedNCT00382603Not applicable
• IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive TherapyCompletedNCT00382226Phase 4
• Prevalence of Ocular Surface Disease in Glaucoma PatientsCompletedNCT00382122
• A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00372931Phase 2
• Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT00372827Phase 4
• A Bioequivalence Study of Tobradex AFCompletedNCT00362895Phase 3
• Safety/Efficacy of Systane Free vs Refresh LiquigelCompletedNCT00348517Not applicable
• Safety/Efficacy of Systane Free vs Refresh TearsCompletedNCT00348322Not applicable
• Product Preference With Systane Compared to Artificial Tears on Frequency of Drop UseCompletedNCT00347984Not applicable
• Fluorophotometry Evaluation of Lubricant Eye DropsCompletedNCT00347854Not applicable
• A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular DegenerationCompletedNCT00346957Phase 2
• Anecortave Acetate Versus Placebo in AMD Patients Following PDTCompletedNCT00346866Phase 2
• Safety of NGOIS Compared to BSS Plus in Pediatric PatientsCompletedNCT00346528Phase 3
• Compliance With Once Daily Glaucoma MedicationCompletedNCT00333463
• Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS PlusCompletedNCT00333268Phase 3
• Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract SurgeryCompletedNCT00333255Phase 3
• Anecortave Acetate Risk-Reduction Trial (AART)TerminatedNCT00333216Phase 3
• Next Generation Ophthalmic Irrigating Solution Posterior Segment StudyCompletedNCT00333203Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00333125Phase 3
• Nevanac 3-Month Safety Study With QID DosingCompletedNCT00332774Phase 3
• Anecortave Acetate Risk Reduction Trial (AART)TerminatedNCT00332657Phase 3
• AL-15469A for the Treatment of Bacterial ConjunctivitisCompletedNCT00332293Phase 3
• AL-15469A for the Treatment of Bacterial ConjunctivitisCompletedNCT00331916Phase 3
• Olopatadine 0.2% for the Treatment of Allergic ConjunctivitisCompletedNCT00331500Phase 3
• A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain ReliefCompletedNCT00330798Phase 4
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00326092Phase 2
• Anecortave Acetate in Patients With Open-angle GlaucomaCompletedNCT00320203Phase 2
• Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) ElevationCompletedNCT00315640Phase 2
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00314171Phase 3
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00314158Phase 3
• A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00311389Phase 3
• Anecortave Acetate Risk-Reduction Trial (AART)TerminatedNCT00307398Phase 3
• Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular HypertensionCompletedNCT00300079Phase 4
• Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)CompletedNCT00299507Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293800Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293787Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293761Phase 3
• Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00288951Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00287521Phase 2
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00069719Phase 2

← Alcon overview and focus areas